99 related articles for article (PubMed ID: 8641641)
1. Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's disease patients.
Zinzani PL; Gherlinzoni F; Piovaccari G; Frezza G; Bendandi M; Ferretti RM; Barbieri E; Fiacchini M; Babini L; Magnani B; Tura S
Haematologica; 1996; 81(2):132-7. PubMed ID: 8641641
[TBL] [Abstract][Full Text] [Related]
2. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
[TBL] [Abstract][Full Text] [Related]
3. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease.
Heidenreich PA; Schnittger I; Strauss HW; Vagelos RH; Lee BK; Mariscal CS; Tate DJ; Horning SJ; Hoppe RT; Hancock SL
J Clin Oncol; 2007 Jan; 25(1):43-9. PubMed ID: 17194904
[TBL] [Abstract][Full Text] [Related]
4. Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity.
Brusamolino E; Lunghi F; Orlandi E; Astori C; Passamonti F; Baraté C; Pagnucco G; Baio A; Franchini P; Lazzarino M; Bernasconi C
Haematologica; 2000 Oct; 85(10):1032-9. PubMed ID: 11025593
[TBL] [Abstract][Full Text] [Related]
5. [Side effects of percutaneous radiotherapy in the area of the thorax: cardiac toxicity of mantle field irradiation].
Huber K
Bildgebung; 1991; 58 Suppl 1():23-5. PubMed ID: 1799841
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
7. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
Koontz BF; Kirkpatrick JP; Clough RW; Prosnitz RG; Gockerman JP; Moore JO; Prosnitz LR
J Clin Oncol; 2006 Feb; 24(4):605-11. PubMed ID: 16446333
[TBL] [Abstract][Full Text] [Related]
8. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced coronary artery disease in Hodgkin's disease.
Miltényi Z; Keresztes K; Garai I; Edes I; Galajda Z; Tóth L; Illés A
Cardiovasc Radiat Med; 2004; 5(1):38-43. PubMed ID: 15275631
[TBL] [Abstract][Full Text] [Related]
10. [Radiation toxicity to the heart: physiopathology and clinical data].
Giraud P; Cosset JM
Bull Cancer; 2004 Nov; 91 Suppl 3():147-53. PubMed ID: 15899621
[TBL] [Abstract][Full Text] [Related]
11. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
12. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
Chow LM; Nathan PC; Hodgson DC; Jenkin D; Weitzman S; Grant RM; Manson D; Bross A; Doyle JJ; Danjoux C; Greenberg ML
J Clin Oncol; 2006 Dec; 24(36):5735-41. PubMed ID: 17179107
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
[TBL] [Abstract][Full Text] [Related]
14. [High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases].
Zhou SY; Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou AP; Feng FY
Ai Zheng; 2002 Apr; 21(4):405-8. PubMed ID: 12452021
[TBL] [Abstract][Full Text] [Related]
15. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.
Adams MJ; Lipsitz SR; Colan SD; Tarbell NJ; Treves ST; Diller L; Greenbaum N; Mauch P; Lipshultz SE
J Clin Oncol; 2004 Aug; 22(15):3139-48. PubMed ID: 15284266
[TBL] [Abstract][Full Text] [Related]
17. Diastolic dysfunction after mediastinal irradiation.
Heidenreich PA; Hancock SL; Vagelos RH; Lee BK; Schnittger I
Am Heart J; 2005 Nov; 150(5):977-82. PubMed ID: 16290974
[TBL] [Abstract][Full Text] [Related]
18. Cardiac risk after mediastinal irradiation for Hodgkin's disease.
Glanzmann C; Kaufmann P; Jenni R; Hess OM; Huguenin P
Radiother Oncol; 1998 Jan; 46(1):51-62. PubMed ID: 9488128
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease.
Hancock SL; Tucker MA; Hoppe RT
JAMA; 1993 Oct; 270(16):1949-55. PubMed ID: 8411552
[TBL] [Abstract][Full Text] [Related]
20. Severe valvular toxicity and pericarditis early after radiation therapy in a patient treated for Hodgkin's lymphoma.
Ramyar A; Shafiei M; Moazzami K; Rezaei N
Turk J Pediatr; 2010; 52(4):423-5. PubMed ID: 21043392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
